• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by ContextLogic Inc.

    3/12/25 4:41:37 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $LOGC alert in real time by email
    S-8 1 2025_evergreen_form_s-8.htm S-8 S-8

     

    As filed with the Securities and Exchange Commission on March 12, 2025

    Registration No. 333-

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

     

    FORM S-8

    REGISTRATION STATEMENT

    Under

    The Securities Act of 1933

    CONTEXTLOGIC INC.

    (Exact name of Registrant as specified in its charter)

    Delaware

    (State or other jurisdiction of

    incorporation or organization)

    27-2930953

    (IRS Employer

    Identification No.)

     

    2648 International Blvd., Ste 115

    Oakland, CA 94601

    (415) 965-8476

    (Address of Principal Executive Offices)

     

     

    ContextLogic Inc. 2020 Equity Incentive Plan

    (Full title of Plan)

     

     

    Rishi Bajaj

    Chief Executive Officer

    ContextLogic Inc.

    2648 International Blvd., Ste 115

    Oakland, CA 94601

    (Name and address of agent for service)

    (415) 965-8476

    (Telephone number, including area code, of agent for service)

    Copies to:

    David A. Curtiss

    Schulte Roth & Zabel LLP

    919 Third Ave.

    New York, NY 10022

    (212) 756-2000

    Marianne Lewis

    ContextLogic Inc.

    2648 International Blvd., Ste 115

    Oakland, CA 94601

    (415) 965-8476

     

     

     

    Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company" in Rule 12b-2 of the Exchange Act.

    Large accelerated filer ☐

    Accelerated filer ☒

    Non-accelerated filer ☐

    Smaller reporting company ☒

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     


     

    EXPLANATORY NOTE

    Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement is filed by ContextLogic Inc. (the “Registrant”) for the purpose of registering 1,314,966 additional shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Common Stock”) under the Registrant’s 2020 Equity Incentive Plan pursuant to the provisions of the plan that provide for automatic annual increases in the number of shares reserved for issuance thereunder. This Registration Statement hereby incorporates by reference the contents of the Registrant’s registration statements on Form S-8 filed with the Securities and Exchange Commission on December 16, 2020, March 14, 2022, February 27, 2023, and March 5, 2024 (File Nos. 333-251374, 333-263538, 333-270074 and 333-277676 respectively) to the extent not superseded hereby.

    PART II

    Information Required in the Registration Statement

    Item 3. Incorporation of Documents by Reference

    ContextLogic Inc., or the Registrant, hereby incorporates by reference into this Registration Statement the following documents (excluding any portions of any Form 8-K that are not deemed “filed” pursuant to the General Instructions of Form 8-K):

    (a) the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 12, 2025;

    (b) the Registrant’s Amendment No. 1 to Quarterly Report on Form 10-Q/A for the quarter ended September 30, 2024 filed with the SEC on February 13, 2025;

    (c) the Registrant’s Current Reports on Form 8-K filed with the SEC on February 28, 2025, March 11, 2025, and March 12, 2025; and

    (d) the description of the Registrant’s common stock contained in the Company’s Description of Capital Stock, filed as Exhibit 4.4 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 12, 2025.

    All other reports and documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, subsequent to the filing of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents. The Registrant is not, however, incorporating any documents or information that the Registrant is deemed to furnish and not file in accordance with SEC rules. Any statement contained in a document incorporated or deemed incorporated by reference in this Registration Statement will be deemed modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document that also is deemed incorporated by reference in this Registration Statement modifies or supersedes that statement.

     


     

    Item 8. Exhibits

    The following exhibits are incorporated herein by reference.

    EXHIBIT INDEX

    Incorporated by Reference

    Exhibit

    Number

    Description

    Form

    File No.

    Exhibit

    Filing

    Date

    Filed

    Herewith

    4.1

     

    Specimen Class A common stock certificate of the Registrant.

     

     

    S-1/A

    333-250531

    4.1

    12/7/2020

     

     

    4.2

    Restated Certificate of Incorporation, as amended through April 23, 2023.

     

    10-Q

    001-39775

     

    3.1

     

    05/04/2023

    4.3

    Amended and Restated Bylaws, effective as of August 5, 2024.

     

    8-K

    001-39775

     

    3.1

     

    08/08/2024

    5.1

    Opinion and Consent of Schulte Roth & Zabel LLP.

     

         X

    23.1

    Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.

     

    X

    23.2

     

    Consent of BPM LLP, Independent Registered Public Accounting Firm.

     

     

     

     

     

     

     

     

     

     

    X

    23.3

    Consent of Schulte Roth & Zabel LLP (contained in Exhibit 5.1).

     

     

     

    X

    24.1

    Power of Attorney (contained in the signature page hereto).

     

    X

    99.1

    ContextLogic Inc. 2020 Equity Incentive Plan and forms of agreements thereunder.

     

    S-8

     

    333-251374

     

    99.2

     

    12/16/2020

    107

    Calculation of Filing Fee Tables.

     

     

     

     

     

     

     

    X

     

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Oakland, State of California on this 12th day of March, 2025.

    ContextLogic Inc.

     

    By:

    /s/ Rishi Bajaj

     

    Rishi Bajaj

     

    Chief Executive Officer

     

     


     

    POWER OF ATTORNEY

    KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears below constitutes and appoints Rishi Bajaj, Brett Just, and Marianne Lewis, and each of them, his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this registration statement, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of the date indicated.

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

    Signature

    Title

    Date

     

     

     


    /s/ Rishi Bajaj

    Rishi Bajaj

    Chief Executive Officer
    (Principal Executive Officer)

    March 12, 2025


    /s/ Brett Just

    Brett Just

    Chief Financial Officer
    (Principal Financial and Accounting Officer)

    March 12, 2025

     

    /s/ Ted Goldthorpe
    Ted Goldthorpe

    Chairman

    March 12, 2025


    /s/ Michael Farlekas

    Michael Farlekas

    Director

    March 12, 2025


    /s/ Marshall Heinberg
    Marshall Heinberg

    Director

    March 12, 2025


    /s/ Elizabeth A. LaPuma
    Elizabeth A. LaPuma

    Director

    March 12, 2025


    /s/ Richard Parisi
    Richard Parisi

    Director

    March 12, 2025

     

    /s/ Mark Ward
    Mark Ward

    Director

    March 12, 2025

     

     

     


    Get the next $LOGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LOGC

    DatePrice TargetRatingAnalyst
    2/3/2022Outperform → Market Perform
    William Blair
    2/2/2022$16.00 → $6.00Hold
    Chardan Capital
    12/23/2021$20.00 → $16.00Buy
    Chardan Capital
    11/17/2021$24.00 → $8.00Overweight
    Barclays
    11/16/2021$17.00 → $16.00Market Outperform
    JMP Securities
    More analyst ratings

    $LOGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • LogicBio Therapeutics downgraded by William Blair

      William Blair downgraded LogicBio Therapeutics from Outperform to Market Perform

      2/3/22 4:38:49 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chardan Capital reiterated coverage on LogicBio Therapeutics with a new price target

      Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Hold and set a new price target of $6.00 from $16.00 previously

      2/2/22 2:52:41 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chardan Capital reiterated coverage on LogicBio Therapeutics with a new price target

      Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Buy and set a new price target of $16.00 from $20.00 previously

      12/23/21 8:24:38 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Bajaj Rishi converted options into 55,856 shares and covered exercise/tax liability with 24,722 shares, increasing direct ownership by 156% to 51,134 units (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      5/8/25 4:10:12 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Director Heinberg Marshall converted options into 25,684 shares (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      4/21/25 8:44:49 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Director Farlekas Michael converted options into 25,684 shares (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      4/21/25 8:44:13 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ContextLogic Inc.

      SC 13G/A - ContextLogic Inc. (0001822250) (Subject)

      7/8/24 4:32:41 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13G/A filed by LogicBio Therapeutics Inc. (Amendment)

      SC 13G/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)

      2/14/23 1:47:10 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13D/A filed by LogicBio Therapeutics Inc. (Amendment)

      SC 13D/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)

      2/10/23 4:40:05 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    SEC Filings

    See more

    $LOGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SEC Form 10-Q filed by ContextLogic Inc.

      10-Q - ContextLogic Inc. (0001822250) (Filer)

      5/9/25 4:30:19 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ContextLogic Inc. (0001822250) (Filer)

      5/9/25 4:05:15 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13G/A filed by ContextLogic Inc.

      SCHEDULE 13G/A - ContextLogic Inc. (0001822250) (Subject)

      4/18/25 3:58:12 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. Reports First-Quarter 2025 Financial Results

      OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025. First-Quarter 2025 Financial Highlights Net Loss: Net loss was $4 million, compared to a net loss of $59 million in the first quarter of fiscal year 2024.As of March 31, 2025, the Company had $64 million in cash and cash equivalents, $158 million in marketable securities and $1 million in prepaid expenses and other current assets primarily made up of restricted cash. The Company had total liabilities of $3 million. ContextLogic will host a financial results conference call a

      5/9/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic to Announce First Quarter 2025 Results on May 9, 2025

      OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on Friday, May 9, 2025. ContextLogic's CEO Rishi Bajaj and its Chairman Ted Goldthorpe will host a live conference call and webcast for shareholders, analysts and portfolio managers that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the Company's financial results, including a link to the live webcast and replay will be made available on the Company's investor relations website at https://ir.contextlogicinc.com. The live conference call may be accessed by registering

      5/6/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

      OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company's business. These included, first, the sale of the Wish platform and its associated operations; second, streamlining the Company's operations; and most recently, on March 11, 2025, the Company announced the initial closing of the investment by BC Partners of $75 million in convertible preferred units in a subsidiary of ContextLogic. This investment, along

      3/12/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Financials

    Live finance-specific insights

    See more
    • ContextLogic Inc. Reports First-Quarter 2025 Financial Results

      OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025. First-Quarter 2025 Financial Highlights Net Loss: Net loss was $4 million, compared to a net loss of $59 million in the first quarter of fiscal year 2024.As of March 31, 2025, the Company had $64 million in cash and cash equivalents, $158 million in marketable securities and $1 million in prepaid expenses and other current assets primarily made up of restricted cash. The Company had total liabilities of $3 million. ContextLogic will host a financial results conference call a

      5/9/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic to Announce First Quarter 2025 Results on May 9, 2025

      OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on Friday, May 9, 2025. ContextLogic's CEO Rishi Bajaj and its Chairman Ted Goldthorpe will host a live conference call and webcast for shareholders, analysts and portfolio managers that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the Company's financial results, including a link to the live webcast and replay will be made available on the Company's investor relations website at https://ir.contextlogicinc.com. The live conference call may be accessed by registering

      5/6/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

      OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company's business. These included, first, the sale of the Wish platform and its associated operations; second, streamlining the Company's operations; and most recently, on March 11, 2025, the Company announced the initial closing of the investment by BC Partners of $75 million in convertible preferred units in a subsidiary of ContextLogic. This investment, along

      3/12/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Leadership Updates

    Live Leadership Updates

    See more
    • ContextLogic Announces Up to $150 Million Strategic Investment by BC Partners

      Strategic investment and capital commitment positions the Company to execute on its stated acquisition-led value maximization strategy; ContextLogic to have up to $300 million of investible cash Ted Goldthorpe, Head of BC Partners Credit, expected to be named Chairman of the Board OAKLAND, Calif. and NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") and BC Partners, an alternative investment manager with c.€40 billion in assets under management, today announced that a fund advised by BC Partners Advisors L.P. will purchase up to $150 million of convertible preferred units (the "Preferred Units") of ContextLogic Holdings, L

      2/25/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business Updates

      LEXINGTON, Mass., March 4, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today reported financial results for the year ended December 31, 2021, and provided business updates. "At LogicBio, we are continuing to advance our mission to safely deliver novel genetic medicines to people impacted by devastating, early onset diseases," said Frederic Chereau, president and chief executive officer of LogicBio. "We are pleased to report that the serious adverse event experienced by the fourth patient enrolled in our Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with methylmalonic acidemia has resolved." Recent Business Update

      3/4/22 4:05:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments

      LEXINGTON, Mass., May 19, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced the promotion of Daniel Gruskin, MD, as chief medical officer. Dr. Gruskin most recently served as senior vice president and head of clinical development. The Company also announced the appointment of Stephen Boyer, PhD, as vice president of regulatory and quality affairs, and Peter Pechan, PhD, as vice president of gene therapy, who will support progress in the Phase I/II SUNRISE clinical trial of LB-001, the Company's investi

      5/19/21 7:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary